The ADOPT trial (Assessment of Efficacies of Cardiac Resynchronization Therapies (CRT-P/D) for Heart Failure Patients in China): rationale, design, and end-points

References

• Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112:e154–e235.
   PubMed Web of Science ®Google Scholar
• Adams KF Jr. New epidemiologic perspectives concerning mild-to-moderate heart failure. Am J Med. 2001;110 Suppl 7A:6S-13S.
   Google Scholar
• Cleland JG, Alamgir F, Nikitin NP, Clark AL, Norell M. What is the optimal medical management of ischemic heart failure?. Prog Cardiovasc Dis. 2001;43:433–455.
   Web of Science ®Google Scholar
• Gu D, Huang G, Wu X, et al. Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chinese Journal of Cardiology. 2003;31:3–6.
   Google Scholar
• MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 1999;353:2001–2007.
   PubMed Web of Science ®Google Scholar
• O’Connell JB. The economic burden of heart failure. Clin Cardiol. 2000;23:III6-III10.
   Web of Science ®Google Scholar
• Khand A, Gemmel I, Clark AL, Cleland JG. Is the prognosis of heart failure improving? J Am Coll Cardiol. 2000;36:2284–2286.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Clark AL. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol 2003;42:1234–1237.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Freemantle N. Cardiac resynchronization for progressive heart failure. JAMA. 2003;290:36–37; Author reply 37–38.
   Web of Science ®Google Scholar
• Stellbrink C, Breithardt OA, Franke A, et al. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38:1957–1965.
   PubMed Web of Science ®Google Scholar
• Gras D, Mabo P, Tang T, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol. 1998;21:2249–2255.
   PubMed Web of Science ®Google Scholar
• Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–880.
   PubMed Web of Science ®Google Scholar
• Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–118.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–1853.
   PubMed Web of Science ®Google Scholar
• Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289:730–740.
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–1549.
   PubMed Web of Science ®Google Scholar
• Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26: 1115–1140.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang S, Hua W, et al. Clinical application of biventricular pacing to treat congestive heart failure. Chin J Cardiac Arrhyth. 1999;3: 245–248.
   Google Scholar
• Hua W, Wang F, Zhang S, et al. The hymodynamic observation on patients with congestive heart failure treated by biventricular pacing. Chin J Cardiac Arrhyth. 2000;4:90–93.
   Google Scholar
• Shen F, Huang Y, Shen Y, et al. Clinical application of biventricular pacing. Chin J Cardiac Arrhyth. 2000;4:94–96.
   Google Scholar
• Wang S, Huang D, Wen S, Wang H. Reproducibility of head up tilt testing results in patients with cardioinhibitory vasovagal syncope. Chin J Cardiac Arrhyth. 2000;4:270–272.
   Google Scholar
• Hua W, Niu HX, Wang FZ, Zhang S, Chen KP, Chen X. Short-term effect of cardiac resynchronization therapy in patients with ischaemic or nonis-chaemic cardiomyopathy. Chin Med J (Engl). 2006;119:1507–1510.
   Web of Science ®Google Scholar
• Wang F, Zhang S, Huang D, et al. Guideline for cardiac resynchronization therapy in patients with chronic heart failure. Chin J Cardiac Arrhyth. 2006;10:90–102.
   Google Scholar
• Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail. 2000;6: 276–285.
   PubMed Web of Science ®Google Scholar
• Abraham WT. Rationale and design of a randomized clinical trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with advanced heart failure: the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). J Card Fail. 2000;6: 369–380.
   Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail. 2001;3:481–489.
   PubMed Web of Science ®Google Scholar
• Shih JH. Sample size calculation for complex clinical trials with survival endpoints. Control Clin Trials. 1995;16:395–407.
   PubMedGoogle Scholar